The role of cell-substrate interaction in regulating osteoclast activation: Potential implications in targeting bone loss in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 69, Issue SUPPL. 1, 2010, Pages

  McHugh, K P ^a   Shen, Z ^a   Crotti, T N ^b   Flannery, M R ^a   O'Sullivan, R P ^a   Purdue, P E ^c   Goldring, S R ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CALCITONIN; CATHEPSIN K; CHLORDANE; OSTEOCLAST DIFFERENTIATION FACTOR; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CELL MARKER; COLONY STIMULATING FACTOR 1; MATRIX METALLOPROTEINASE;

BONE MATRIX; BONE MINERALIZATION; CELL ACTIVATION; CELL INTERACTION; GENE EXPRESSION; INFLAMMATORY CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; BONE STRUCTURE; CELL ACTIVITY; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURFACE; ENZYME ACTIVITY; HUMAN; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE RESORPTION; CELL DIFFERENTIATION; HUMANS; MICE; OSTEOCLASTS; SIGNAL TRANSDUCTION;

EID: 75749140068     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.120188     Document Type: Review

References (23)

1. Teitelbaum SL. Osteoclasts: what do they do and how do they do it? Am J Pathol 2007;170:427-35.
2. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003;4:638-49.
3. McHugh KP, Shen Z, Crotti TN, et al. Role of cell-matrix interactions in osteoclast differentiation. Adv Exp Med Biol 2007;602:107-11.
4. Shen Z, Crotti TN, McHugh KP, et al. The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Arthritis Res Ther 2006;8:R70.
5. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007;7:292- 304.
6. Josien R, Wong BR, Li HL, et al. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999;162:2562-8.
7. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
8. Wong BR, Josien R, Lee SY, et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997;186:2075-80.
9. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13:2412-24.
10. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-23.
11. Athanasou NA, Quinn J, Horton MA, et al. New sites of cellular vitronectin receptor immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13c2 and 23c6. Bone Miner 1990;1:7.
12. Ishikawa H, Hirata S, Nishibayashi Y, et al. The role of adhesion molecules in synovial pannus formation in rheumatoid arthritis. Clin Orthop 1994;300:297-303.
13. Veale D, Rogers S, Fitzgerald O. Immunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skin. Br J Dermatol 1995;132:32-8.
14. Alvarez JI, Teitelbaum SL, Blair HC, et al. Generation of avian cells resembling osteoclasts from mononuclear phagocytes. Endocrinology 1991;128:2324-35.
15. Karsdal MA, Larsen L, Engsig MT, et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 2002;277:44061-7.
16. Messent AJ, Tuckwell DS, Knauper V, et al. Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion. J Cell Sci 1998;111(Pt 8):1127-35.
17. Holliday LS, Welgus HG, Fliszar CJ, et al. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 1997;272:22053-8.
18. Zhao W, Byrne M, Boyce B, et al. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mice. J Clin Invest 1999;103:517-24.
19. Duong LT, Lakkakorpi P, Nakamura I, et al. Integrins and signaling in osteoclast function. Matrix Biol 2000;19:97-105.
20. Inoue M, Ross FP, Erdmann JM, et al. Tumor necrosis factor alpha regulates alpha(v)beta5 integrin expression by osteoclast precursors in vitro and in vivo. Endocrinology 2000;141:284-90.
21. McHugh KP, Hodivala-Dilke K, Zheng MH, et al. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 2000;105:433-40.
22. Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 1984;27:968-75.
23. Gravallese EM, Harada Y, Wang JT, et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998;152:943-51.